跳至主要内容
临床试验/NCT03172221
NCT03172221已完成不适用

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women

Foundation for Innovative New Diagnostics, Switzerland2 个研究点 分布在 1 个国家目标入组 880 人开始时间: 2017年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
880
试验地点
2
主要终点
Diagnostic accuracy

研究概览

简要总结

This is a cross-sectional and multicentre clinical trial to study the performance of the Histidine Rich Protein 2 (HRP2) highly sensitive rapid diagnostic test (HS-RDT) for the detection of malaria during pregnancy in low transmission settings from Colombia and Indonesia. The new HS-RDT will be compared with conventional good quality RDTs, microscopy, and NAATs [loop-mediated isothermal amplification (LAMP), nested PCR (nPCR)], in peripheral blood samples with quantitative reverse transcription PCR (qRT-PCR) as reference standard.

详细描述

The activities proposed will be performed in the context of health centres receiving pregnant women for antenatal care visit. Finger-prick blood (300 µL) will be collected and used to test for malaria with the HS-RDT, as well as with conventional good quality RDTs, microscopy and local NAATs (LAMP and nPCR). Dried blood spots will also be collected for qRT-PCR testing. Patient information (demographics, obstetric history, malaria prevention measures, etc.) as well as laboratory results will be recorded and entered into a dedicated database.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with confirmed pregnancy and registered to the antenatal care programme in the local health centre
  • Resident for at least 1 year in the study site
  • Accepting to participate with willingness to give informed consent (pregnant adolescents younger than 18 y/o (age < 18) will be considered only if they are accompanied by parent or carer if it is requested by local Institutional Review Boards)
  • Willingness to provide finger-prick blood sample at enrolment

排除标准

  • Past history of malaria and/or antimalarial drugs in the last three months
  • Positive for malaria by microscopy and conventional RDT testing in any previous study screening visit
  • Presence of severe malaria as defined by WHO guidelines at the moment of recruitment
  • Presence of symptoms and signs of other severe disease and central nervous system infections, as defined by WHO guidelines.

结局指标

主要结局

Diagnostic accuracy

时间窗: 1 year

Sensitivity, specificity, negative predictive value, positive predictive value, diagnostic odds ratio (DOR) and the area under the receiver operating characteristic curve (AUROC) of HRP2 HS-RDT for the detection of P. falciparum during pregnancy, compared with conventional good quality RDTs, microscopy and NAATs (LAMP, nPCR,), in peripheral blood with qRT-PCR as reference standard.

次要结局

未报告次要终点

研究者

发起方
Foundation for Innovative New Diagnostics, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验